We’re about to witness a paradigm shift in how diseases are being diagnosed.
Next up — clinical trials.
There is a long-lasting debate dividing the cancer researchers community over the point at which a skin lesion is considered a melanoma. A University of California-San Francisco team led by Hunter Shain might have found the answers to settle the debate once and for all; they have found a way to tell whether a lesion is harmless or growing into a melanoma.
A new clinical trial from the UK brings exciting results as a modified strain of the herpes virus has been successfully used to treat skin cancer patients, with only minor side effect.
You hear about potential cancer treatments all the time, and despite significant and remarkable improvements, we’re still miles away from an actual cure for cancer; so what makes this therapy so great? Well… it just seems to work – on humans, suffering from cancer, not in a lab. For one woman, it seems to have completely dissolved a big tumor in just three weeks, and overall, 53% of patients experienced at least 80% tumor shrinkage.
Contrary to popular belief, much of the damage inflicted to the skin by harmful ultraviolet (UV) light occurs hours after exposure to the sun, even when you’re sitting comfortably asleep in your dark bedroom. The Yale University research also made a startling find: melanin – the pigment that gives human skin and hair its colour – has both carcinogenic and protective effects. This double standard should be taken into consideration from now on when discussing UV exposure, but also when looking for new treatments to skin cancers like melanoma.
The risk of possibly the most dangerous type of cancer out there, melanoma, is greatly increased by exposure to sun in early adulthood. According to a new study conducted on Caucasian women, five or more blistering sun burns may increase the risk of melanoma by 80 percent. “Our results suggest that sun exposures in both early life and adulthood were
A cross-disciplinary team of scientists at Harvard that developed a novel type of vaccine for treating melanoma – the most lethal form of skin cance – recently announced the vaccine will enter its Phase 1 clinical trial. The announcement comes just a few years after the vaccine was tested on mice, 50% of whom showed signs of complete tumor regression.
Researchers have shown that it’s genes, and not the Sun which increases the risk of melanoma in redheads. Doctors previously believed that their pale skin, often covered with freckles just didn’t provide as much protection towards UV’s, but new research showed that genetic factors of the skin pigment are the real culprits here. “We’ve known for a long time